Clinical and biochemical characteristics of the class I obesity patient in Mexico. Med Int Méx 2024; 40 (3): 201-210. https://doi.org/10.24245/mim.v40i3.9688 Francisco J Nachón García,1,2 Gabriela E Saldaña Dávila,2 Natalia Nachón Aguayo,1 César Ochoa Martínez3 1 Instituto…
Associated factors to death in COVID-19 positive patients in Tamaulipas, Mexico. Med Int Méx 2023; 39 (6): 843-853. https://doi.org/10.24245/mim.v39i6.8685 Verónica Martínez Lara,1 Dionicio Morales Ramírez,2 Mayra Vázquez Meza3 1 Médico familiar, adscrito a la Unidad…
Use of factor Xa/direct oral anticoagulants inhibitors compared to warfarin in obese patients. Med Int Méx 2023; 39 (4): 629-641. https://doi.org/10.24245/mim.v39i4.6965 Dennis Ximena Murcia Acero,1 Mónica Paola Quemba Mesa2 1 Residente de Ginecología y…
Effect of obesity in burned patients. Med Int Méx 2023; 39 (3): 464-481. https://doi.org/10.24245/mim.v39i3.6825 Raúl Carrillo-Esper,1 Roberto Emmanuel Islas-Ávila,2 Karen Itzel González-Martínez2 1 Academia Nacional de Medicina. Subdivisión de Áreas Críticas, Instituto Nacional de Rehabilitación…
Multidisciplinary approach of overweight and obesity in adults. Med Int Méx 2023; 39 (2): 329-366. https://doi.org/10.24245/mim.v39i2.8511 Eduardo Meneses-Sierra,1 Cesar Ochoa-Martínez,2 Erick Burciaga-Jiménez,3 Rubén Gómez-Mendoza,4 Juan Luis Salgado-Loza,5 Tania Marisol Peña-Arriaga,6 Miguel Díaz-Aguilera,7 Ana Isabel Burguete-García,8 Stephany Michelle Márquez-González,9 Gad Gamed Zavala-Cruz,10 Erika…
Stigmatization of patients with obesity in the medical and social context. Med Int Méx 2022; 38 (4): 914-920. https://doi.org/10.24245/mim.v38i4.6831 Christian Emmanuel Guendulain-Sernas,1 Isaías Hernández-Torres,2 Geovani López-Ortiz3 1 Médico pasante de servicio social de la licenciatura…
Obesity in the female vital cycle, and its association with monthly disorders. Med Int Méx 2022; 38 (2): 344-354. https://doi.org/10.24245/mim.v38i2.3799 Alex Ramírez-Rincón,1,3,6 Luis Miguel Ruiz-Velásquez,2,4 Sandra Mora-Thiriez,5 Santiago Saldarriaga-Betancur2,6 1 Médico internista. Endocrinólogo. 2 Médico residente de…
Lorcaserin: a new alternative for the treatment of obesity. Med Int Méx 2022; 38 (1): 121-129. https://doi.org/10.24245/mim.v38i1.3733 Jorge Yamamoto-Cuevas,1 Paloma Almeda-Valdés,2 Guadalupe Castro-Martínez,3 Manuel Duarte-Vega,4 Gerardo González-Girón,5 Fernando Javier Lavalle-González,6 Hugo Antonio Laviada-Molina,7 José Agustín Mesa-Pérez,8 Roopa Pravin-Mehta,9 J Héctor Sánchez-Mijangos,10 Rafael…
Pharmacological treatment of diabetes mellitus type 2 directed to patients with overweight and obesity. Med Int Méx. 2019 julio-agosto;35(4):525-536. https://doi.org/10.24245/mim.v35i4.2486 Raúl Mellado-Orellana,1 Erika Salinas-Lezama,1 Diana Sánchez-Herrera,1 Jaime Guajardo-Lozano,1 Enrique Juan Díaz-Greene,3 Federico Leopoldo Rodríguez-Weber2 1 Residente de Medicina…
Med Int Méx. 2017 noviembre;33(6):770-777. DOI: https://doi.org/10.24245/mim.v33i6.1672 Gómez-Romero P1, Alarcón-Sotelo A1, Rodríguez-Weber F2, Díaz-Greene E3 1 Residente de Medicina Interna. 2 Profesor adjunto del curso de Medicina Interna. 3 Profesor titular del curso de Medicina…